CVE-2022-45611 Information disclosure in n/a
Attackers can capture user login information to gain escalated privileges in Fresenius Kabi PharmaHelp.
- Exploited in the wild
- Not known
- Login needed
- Not needed
- Attackable
- Over the internet
- Victim action needed
- Not needed
- Fix
- None listed
What is CVE-2022-45611?
CVE-2022-45611 is a critical vulnerability in n/a, published on 22 Aug 2023. An attacker can exploit it over the internet without logging in, with no action from the victim.
Official description
An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.
Weakness: CWE-522
Which versions are affected by CVE-2022-45611?
It affects 1 product.
Products include Fresenius-Kabi Pharmahelp Firmware.
How do I fix CVE-2022-45611?
No fix has been published for CVE-2022-45611 yet. Limit exposure of the affected software until one is available.
Is CVE-2022-45611 being exploited?
There is no known exploitation of CVE-2022-45611 in the wild and no public exploit code.
Sources
Also known as GHSA-7qc3-f88f-rqhv.